Without savings from the 340B Drug Pricing Program as a lifeline, hospitals face reductions in service or even closure.
Tom Kraus, J.D.
Advertisement
Tom Kraus, J.D., is chief advocacy officer and vice president of government relations at ASHP (American Society of Health-System Pharmacists) and a member of the Managed Healthcare Executive editorial advisory board.
Articles by Tom Kraus, J.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves new sunscreen ingredient, first time in 20 years
2
FDA sets goal date for ophthalmic version of bevacizumab
3
From ejection to apology: The ADA controversy’s timeline of events
4
The women’s health conversation still has a migraine-sized gap
5